Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Hyperalgesia - Overview
Hyperalgesia - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Hyperalgesia - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Hyperalgesia - Companies Involved in Therapeutics Development
Cara Therapeutics Inc
Charleston Laboratories Inc
H. Lundbeck AS
Novartis AG
Hyperalgesia - Drug Profiles
ABX-1431 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
AX-007 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
BAM-822 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
CR-701 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Drug for Hyperalgesia - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ketoprofen - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
mol-002291 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Monoclol Antibody to Inhibit TGF-Beta-1 for Chronic Pancreatitis Pain and Hyperalgesia - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules to Antagonize GPR4 for Arthritis, Hyperalgesia and Oncology - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ZH-853 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Hyperalgesia - Dormant Projects
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures


Number of Products under Development for Hyperalgesia, H2 2019
Number of Products under Development by Companies, H2 2019
Number of Products by Top 10 Targets, H2 2019
Number of Products by Stage and Top 10 Targets, H2 2019
Number of Products by Top 10 Mechanism of Actions, H2 2019
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2019
Number of Products by Routes of Administration, H2 2019
Number of Products by Stage and Routes of Administration, H2 2019
Number of Products by Molecule Types, H2 2019
Number of Products by Stage and Molecule Types, H2 2019


List of Tables


Number of Products under Development for Hyperalgesia, H2 2019
Number of Products under Development by Companies, H2 2019
Number of Products under Development by Universities/Institutes, H2 2019
Products under Development by Companies, H2 2019
Products under Development by Universities/Institutes, H2 2019
Number of Products by Stage and Target, H2 2019
Number of Products by Stage and Mechanism of Action, H2 2019
Number of Products by Stage and Route of Administration, H2 2019
Number of Products by Stage and Molecule Type, H2 2019
Hyperalgesia - Pipeline by Cara Therapeutics Inc, H2 2019
Hyperalgesia - Pipeline by Charleston Laboratories Inc, H2 2019
Hyperalgesia - Pipeline by H. Lundbeck AS, H2 2019
Hyperalgesia - Pipeline by Novartis AG, H2 2019
Hyperalgesia - Dormant Projects, H2 2019